NCT03831776 2025-06-08
BosuPeg
St. Olavs Hospital
Phase 2 Completed
Clinical Trials
7 trialsNCT02810990 2023-02-03
BEST
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2 Completed
NCT03128411 2022-05-19
Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Pfizer
Phase 2 Completed
NCT02638467 2020-11-05
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy
University of Milano Bicocca
Phase 2 Completed
NCT00261846 2017-07-27
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
Pfizer
Phase 2 Completed
NCT01331291 2016-07-25
Bosutinib in Adult Patients With Recurrent Glioblastoma
Massachusetts General Hospital
Phase 2 Completed
NCT00319254 2013-01-31
Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer
Pfizer
Phase 2 Completed